Receive alerts
Unlisted (UK)
Market Cap:
52 weeks high
52 weeks low

In brief

SMARTCO Research is a market terminal focused on AIM listed and pre-IPO (ie within two years of targeting IPO) companies conforming to an investment template developed by Charles Breese (SMARTCOs). It is a component of Larpent Newton’s SMARTCO Select investment services.

SMARTCO Research is a component of the SMARTCO Select service developed by Charles Breese’s company, Larpent Newton, to provide an investment service to investors interested in investing in SMARTCOs at an annual subscription is £250 pa (incl of VAT) offering the following benefits:

email alerts re new content added to www.SMARTCOresearch.com.
weekly newsletter
access to Audiovisual Content and research from, inter alia, Hardman & Co.
invitations to participate in fundraisings by SMARTCos which are within two years of targeting to IPO or are AIM listed
invitations to attend SMARTCO presentations organised by, inter alia, Hardman & Co.
enabling private investors to be treated similarly to institutional investors whilst being left in control of their investment decisions.

SMARTCOs with Proactive Investors content are:

i) AIM listed:

- AB Dynamics 

- accesso Technology

- Brady

- Cohort

- Collagen Solutions

- Dillistone Group


- Haydale Graphene Industries

- Horizon Discovery Group

- Image Scan

- Instem

- OptiBiotix

- Plastics Capital


- ReNeuron Group

- Scancell Holdings

Stadium Group

- StatPro Group

- Venn Life Science Holdings

ii) Unquoted:

- OR Productivity

Deep dive We explore the investor case for growth companies


The guiding principles of SMARTCO Select were forged in the white heat of Sheffield’s steel industry, according to founder Charles Breese.